IP Library Granted Patent US 7,625,885
Granted Patent B2
US 7,625,885 · App. 10/906,386 · Granted Dec 1, 2009

Cytotoxin compound and method of isolation

Assignees: University of South Florida; The UAB Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,625,885
App. No.
10/906,386
Granted
Dec 1, 2009
Kind
B2
Abstract

A compound or groups of compounds, present in an active principle, derived from tunicates of the species Synoicum adareanum , as well as to pharmaceutical compositions comprising these compounds. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.

Claims (19)

1. A composition comprising an isolated compound of formula I or racemic mixture thereof, or a pharmaceutically acceptable salt thereof, of the formula:

2. The composition of claim 1 , wherein said composition further comprises a pharmaceutically acceptable carrier.

3. A composition comprising an isolated compound of formula II or a pharmaceutically acceptable salt thereof, of the formula:

4. The composition of claim 3 , wherein said composition further comprises a pharmaceutically acceptable carrier.

5. A composition comprising an isolated compound of formula III or a pharmaceutically acceptable salt thereof of the formula:

6. The composition of claim 5 , wherein said composition further comprises a pharmaceutically acceptable carrier.

7. A composition comprising an isolated compound of formula IV or a pharmaceutically acceptable salt thereof, of the formula:

8. The composition of claim 7 , wherein said composition further comprises a pharmaceutically acceptable carrier.

9. The composition of claim 1 , wherein said salt is an acid salt of acetate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate butyrate, citrate, camphorate, camphorsulfonate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, fumarate, glucoheptanoate, glycerophosphate, hemisulfate, heptanoate, hexanoate, hydrochloride hydrobromide, hydroiodide, 2-hydroxyethane-sulfonate, lactate, maleate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, oxalate, thiocyanate, tosylate or undecanoate.

10. The composition of claim 1 , wherein said salt is a base salt of ammonium salts, alkali metal salts, alkaline earth metal salts, salts with organic bases, N-methyl-D-glucamine, or salts with amino acids.

11. The composition of claim 3 , wherein said salt is an acid salt of acetate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate butyrate, citrate, camphorate, camphorsulfonate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, fumarate, glucoheptanoate, glycerophosphate, hemisulfate, heptanoate, hexanoate, hydrochloride hydrobromide, hydroiodide, 2-hydroxyethane-sulfonate, lactate, maleate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, oxalate, thiocyanate, tosylate or undecanoate.

12. The composition of claim 3 , wherein said salt is a base salt of ammonium salts, alkali metal salts, alkaline earth metal salts, salts with organic bases, N-methyl-D-glucamine, or salts with amino acids.

13. The composition of claim 5 , wherein said salt is an acid salt of acetate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate butyrate, citrate, camphorate, camphorsulfonate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, fumarate, glucoheptanoate, glycerophosphate, hemisulfate, heptanoate, hexanoate, hydrochloride hydrobromide, hydroiodide, 2-hydroxyethane-sulfonate, lactate, maleate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, oxalate, thiocyanate, tosylate or undecanoate.

14. The composition of claim 5 , wherein said salt is a base salt of ammonium salts, alkali metal salts, alkaline earth metal salts, salts with organic bases, N-methyl-D-glucamine, or salts with amino acids.

15. The composition of claim 7 , wherein said salt is an acid salt of acetate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate butyrate, citrate, camphorate, camphorsulfonate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, fumarate, glucoheptanoate, glycerophosphate, hemisulfate, heptanoate, hexanoate, hydrochloride hydrobromide, hydroiodide, 2-hydroxyethane-sulfonate, lactate, maleate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, oxalate, thiocyanate, tosylate or undecanoate.

16. The composition of claim 7 , wherein said salt is a base salt of ammonium salts, alkali metal salts, alkaline earth metal salts, salts with organic bases, N-methyl-D-glucamine, or salts with amino acids.

17. A purified compound, or a pharmaceutically acceptable salt thereof, having the formula selected from:

18. The compound of claim 17 , wherein said salt is an acid salt of acetate, adipate, alginate, aspartate, benzoate, benzenesulfonate, bisulfate butyrate, citrate, camphorate, camphorsulfonate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, fumarate, glucoheptanoate, glycerophosphate, hemisulfate, heptanoate, hexanoate, hydrochloride hydrobromide, hydroiodide, 2-hydroxyethane-sulfonate, lactate, maleate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, oxalate, thiocyanate, tosylate or undecanoate.

19. The compound of claim 17 , wherein said salt is a base salt of ammonium salts, alkali metal salts, alkaline earth metal salts, salts with organic bases, N-methyl-D-glucamine, or salts with amino acids.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 20, 2011
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 026319/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2005
From: BAKER, BILL J; DIYABALANAGE, THUSHARA
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 015894/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2005
From: MCCLINTOCK, JAMES B; AMSLER, CHARLES D
To: THE UAB RESEARCH FOUNDATION
Reel/Frame 015830/0180 →
Continuity (2)
Provisional Application 6052107300 · Feb 17, 2004
Related Publication 20050187286A1 · Aug 25, 2005